Record Order Bookings
Order bookings for the fourth quarter were $863 million, up 9% from the fourth quarter last year. Full-year bookings reached $3.3 billion, a record for ATS.
Strong Life Sciences Performance
Life sciences businesses demonstrated strength, ending the quarter with an order backlog of $1.2 billion, supported by diverse bookings in areas such as auto-injector assembly, radiopharma, and wearables.
Improved Gross Margin
Excluding acquisition-related charges, the gross margin for Q4 was 29%, a 90 basis point improvement from last year.
EV Settlement
The company announced a settlement with an EV customer, expecting to receive USD 134.75 million, which will reduce net debt to adjusted EBITDA leverage by 0.5x.
Strong Energy Sector Prospects
The energy sector shows strong growth potential with ongoing CANDU refurbishment projects and opportunities in nuclear fuel and small modular reactors.